Clinical Trial Update: Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/2 safety and immunogenicity study of LC16m8, a modified smallpox vaccine, in healthy volunteers who have not been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• LC16m8

Snippet

Sponsor: VaxGen | Conditions: Smallpox | Phase 1, Phase 2 | Status: UNKNOWN